![1]()
News
Timing of initiation of renal-replacement therapy in acute kidney injury
December 8, 2021
In critically ill patients, does early renal-replacement therapy (RRT), compared with standard therapy, improve death from any cause at 90 days?
![1]()
News
Children and COVID-19: 7 million cases and still counting
December 7, 2021
Over 900,000 children aged 5-11 years completed the vaccine regimen in the last week.
![1]()
News
Compression therapy prevents recurrence of cellulitis
December 7, 2021
Do compression garments prevent recurrent cellulitis in patients with lower-extremity edema?
![1]()
News
Apixaban outmatches rivaroxaban for VTE in study
December 6, 2021
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.
News
Hemostatic powder noninferior in nonvariceal upper GI bleeds
December 6, 2021
TC-325 hemostatic powder compares well with standard endoscopic treatment of acute nonvariceal gastrointestinal bleeding in a new study.
![1]()
News
Care via video teleconferencing can be as effective as in-person for some conditions
December 6, 2021
Video teleconferencing works best for monitoring patients with chronic conditions, according to the author of a new paper.
![1]()
News
Apixaban noninferior to low-molecular-weight heparin in cancer-associated VTE
December 6, 2021
Is oral apixaban as safe and effective as subcutaneous dalteparin in treating venous thromboembolism (VTE) in patients with underlying cancer?
![1]()
News
Antibiotics vs. placebo in acute uncomplicated diverticulitis
December 3, 2021
Does antibiotic therapy decrease length of hospital stay for patients with acute uncomplicated diverticulitis?
News
Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed.
December 3, 2021
“My patient was struggling to breathe, but the family refused to allow me to provide care. A call to the police was the only solution.”
![1]()
News
No serious CV risks for elderly after Pfizer COVID-19 vaccine
December 2, 2021
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.
